These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 34802071)

  • 1. Circulating tumor cells in colorectal cancer in the era of precision medicine.
    Hu M; Wang Z; Wu Z; Ding P; Pei R; Wang Q; Xing C
    J Mol Med (Berl); 2022 Feb; 100(2):197-213. PubMed ID: 34802071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly Correlated Recurrence Prognosis in Patients with Metastatic Colorectal Cancer by Synergistic Consideration of Circulating Tumor Cells/Microemboli and Tumor Markers CEA/CA19-9.
    Chu HY; Yang CY; Yeh PH; Hsu CJ; Chang LW; Chan WJ; Lin CP; Lyu YY; Wu WC; Lee CW; Wu JK; Jiang JK; Tseng FG
    Cells; 2021 May; 10(5):. PubMed ID: 34068719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical application of liquid biopsy in colorectal cancer: detection, prediction, and treatment monitoring.
    Tao XY; Li QQ; Zeng Y
    Mol Cancer; 2024 Jul; 23(1):145. PubMed ID: 39014366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating biomarkers for early detection and clinical management of colorectal cancer.
    Marcuello M; Vymetalkova V; Neves RPL; Duran-Sanchon S; Vedeld HM; Tham E; van Dalum G; Flügen G; Garcia-Barberan V; Fijneman RJ; Castells A; Vodicka P; Lind GE; Stoecklein NH; Heitzer E; Gironella M
    Mol Aspects Med; 2019 Oct; 69():107-122. PubMed ID: 31189073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The rare circulating tumor microemboli as a biomarker contributes to predicting early colorectal cancer recurrences after medical treatment.
    Hao YJ; Chang LW; Yang CY; Lo LC; Lin CP; Jian YW; Jiang JK; Tseng FG
    Transl Res; 2024 Jan; 263():1-14. PubMed ID: 37558203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinico-pathological correlation of serial measurement of circulating tumor cells in 24 metastatic colorectal cancer patients receiving chemotherapy reveals interpatient heterogeneity correlated with CEA levels but independent of KRAS and BRAF mutation.
    Das A; Kunkel M; Joudeh J; Dicker DT; Scicchitano A; Allen JE; Sarwani N; Yang Z; Kaifi J; Zhu J; Liao J; El-Deiry WS
    Cancer Biol Ther; 2015; 16(5):709-13. PubMed ID: 25806877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating Tumor Cells: Overview and Opportunities in Cytology.
    Sundling KE; Lowe AC
    Adv Anat Pathol; 2019 Jan; 26(1):56-63. PubMed ID: 30325755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liquid biopsy at the frontier of detection, prognosis and progression monitoring in colorectal cancer.
    Zhou H; Zhu L; Song J; Wang G; Li P; Li W; Luo P; Sun X; Wu J; Liu Y; Zhu S; Zhang Y
    Mol Cancer; 2022 Mar; 21(1):86. PubMed ID: 35337361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating tumor cell isolation during resection of colorectal cancer lung and liver metastases: a prospective trial with different detection techniques.
    Kaifi JT; Kunkel M; Das A; Harouaka RA; Dicker DT; Li G; Zhu J; Clawson GA; Yang Z; Reed MF; Gusani NJ; Kimchi ET; Staveley-O'Carroll KF; Zheng SY; El-Deiry WS
    Cancer Biol Ther; 2015; 16(5):699-708. PubMed ID: 25807199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating tumor cell levels are elevated in colorectal cancer patients with high tumor burden in the liver.
    Kaifi JT; Kunkel M; Dicker DT; Joude J; Allen JE; Das A; Zhu J; Yang Z; Sarwani NE; Li G; Staveley-O'Carroll KF; El-Deiry WS
    Cancer Biol Ther; 2015; 16(5):690-8. PubMed ID: 25785486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating Tumor Cells in Colorectal Cancer: Detection Systems and Clinical Utility.
    Petrik J; Verbanac D; Fabijanec M; Hulina-Tomašković A; Čeri A; Somborac-Bačura A; Petlevski R; Grdić Rajković M; Rumora L; Krušlin B; Štefanović M; Ljubičić N; Baršić N; Hanžek A; Bočkor L; Ćelap I; Demirović A; Barišić K
    Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Six-gene Assay as a new biomarker in the blood of patients with colorectal cancer: establishment and clinical validation.
    Shou X; Li Y; Hu W; Ye T; Wang G; Xu F; Sui M; Xu Y
    Mol Oncol; 2019 Apr; 13(4):781-791. PubMed ID: 30556647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of Circulating Tumor Cells and Their Implications as a Biomarker for Diagnosis, Prognostication, and Therapeutic Monitoring in Hepatocellular Carcinoma.
    Ahn JC; Teng PC; Chen PJ; Posadas E; Tseng HR; Lu SC; Yang JD
    Hepatology; 2021 Jan; 73(1):422-436. PubMed ID: 32017145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating tumor cells as an independent prognostic factor in advanced colorectal cancer: a retrospective study in 121 patients.
    Wang L; Zhou S; Zhang W; Wang J; Wang M; Hu X; Liu F; Zhang Y; Jiang B; Yuan H
    Int J Colorectal Dis; 2019 Apr; 34(4):589-597. PubMed ID: 30627849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating Tumour Cells as Prognostic Biomarkers in Colorectal Cancer: A Systematic Review.
    Veyrune L; Naumann DN; Christou N
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33918012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic role of circulating tumor cells in colorectal cancer.
    Nanduri LK; Hissa B; Weitz J; Schölch S; Bork U
    Expert Rev Anticancer Ther; 2019 Dec; 19(12):1077-1088. PubMed ID: 31778322
    [No Abstract]   [Full Text] [Related]  

  • 17. Feasibility of a novel one-stop ISET device to capture CTCs and its clinical application.
    Chen F; Wang S; Fang Y; Zheng L; Zhi X; Cheng B; Chen Y; Zhang C; Shi D; Song H; Cai C; Zhou P; Xiong B
    Oncotarget; 2017 Jan; 8(2):3029-3041. PubMed ID: 27935872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liquid biopsy for ovarian cancer using circulating tumor cells: Recent advances on the path to precision medicine.
    Yang J; Cheng S; Zhang N; Jin Y; Wang Y
    Biochim Biophys Acta Rev Cancer; 2022 Jan; 1877(1):188660. PubMed ID: 34800546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating Tumor Cells and Cell-free Nucleic Acids as Biomarkers in Colorectal Cancer.
    Pourali G; Khalili-Tanha G; Nazari E; Maftooh M; Nassiri M; Hassanian SM; Mobarhan MG; Khazaei M; Ferns G; Avan A
    Curr Pharm Des; 2023; 29(10):748-765. PubMed ID: 36892023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating tumor cells exhibit stem cell characteristics in an orthotopic mouse model of colorectal cancer.
    Schölch S; García SA; Iwata N; Niemietz T; Betzler AM; Nanduri LK; Bork U; Kahlert C; Thepkaysone ML; Swiersy A; Büchler MW; Reissfelder C; Weitz J; Rahbari NN
    Oncotarget; 2016 May; 7(19):27232-42. PubMed ID: 27029058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.